Quantcast

Latest Regenesis Biomedical Inc. Stories

2014-10-23 20:29:22

Clinical and strategic insight strengthened in senior management and Board of Directors SCOTTSDALE, Ariz., Oct.

2011-06-06 07:00:00

SCOTTSDALE, Ariz., June 6, 2011 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company that markets the Provant® Therapy System, announced today the closing of a $5.3 million Series C equity financing.

2010-03-02 10:38:00

SCOTTSDALE, Ariz., March 2 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announced today that Peter Sheehan, MD, has joined the company's Board of Directors and will serve as Chairman of their Medical Advisory Board. Dr.

2008-08-22 12:00:52

SCOTTSDALE, Ariz., Aug. 22 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company that markets the Provant(R) Wound Therapy System, announced today the addition of two members to its Board of Directors. The two new directors are Peter G.

2008-06-17 12:00:57

SCOTTSDALE, Ariz., June 17 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company that markets the Provant(R) Wound Therapy System, announced today their accreditation as an Exemplary Provider for Medicare beneficiaries.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.